Clinical Roundup Phase I clinical trial of Keytruda + Lymphir for recurrent solid tumors yields positive preliminary results November 15, 2024Vol.50 No.43
Clinical Roundup USC study identifies innate immune system protein as potential target for CRC immunotherapy November 15, 2024Vol.50 No.43
Clinical Roundup Engineered HSV can trigger genetic chain reaction, rearrange HSV genes during co-infection November 15, 2024Vol.50 No.43
Clinical Roundup Wugen launches phase II study of CD7-targeted CAR T for r/r T-ALL or T-ALL/LBL November 15, 2024Vol.50 No.43
Clinical Roundup Long-term risks from prostate cancer treatment detailed in new report November 08, 2024Vol.50 No.42
Clinical Roundup Ruxolitinib improves CML’s response to standard TKI treatment November 08, 2024Vol.50 No.42
Clinical Roundup Quitting smoking after a cancer diagnosis improves survival November 08, 2024Vol.50 No.42
Clinical Roundup Survey shows dangerous knowledge gaps in pancreatic cancer November 08, 2024Vol.50 No.42
Clinical Roundup AI may be more accurate vs. traditional methods at classifying patients into prostate cancer risk groups November 08, 2024Vol.50 No.42
Clinical Roundup Neuro-oncology experts release clinical practice guidelines for using AI in brain cancer diagnosis, monitoring, treatment November 08, 2024Vol.50 No.42
